UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030635
Receipt number R000034945
Scientific Title Cholesterol Absorption and Cholesterol synthesis in High-risk patiEnts (CACHE study)
Date of disclosure of the study information 2018/01/01
Last modified on 2021/12/03 13:41:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Cholesterol Absorption and Cholesterol synthesis in High-risk patiEnts (CACHE study)

Acronym

Cholesterol Absorption and Cholesterol synthesis in High-risk patiEnts (CACHE study)

Scientific Title

Cholesterol Absorption and Cholesterol synthesis in High-risk patiEnts (CACHE study)

Scientific Title:Acronym

Cholesterol Absorption and Cholesterol synthesis in High-risk patiEnts (CACHE study)

Region

Japan


Condition

Condition

1. Cardiovascular disease (coronary arterial disease, cerebrovascular disease, peripheral arterial disease)
2. Conditions at high risk of cardiovascular disease (diabetes mellitus, chronic kidney disease including stage 5D)
3. Those who do not have the above diseases

Classification by specialty

Medicine in general Cardiology Endocrinology and Metabolism
Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

1. To examine the possible relationship between the markers of cholesterol metabolism and cardiovascular disease.
2. To examine possible alterations in the levels of cholesterol metabolism markers in diabetes mellitus, chronic kidney disease, familial hypercholesterolemia.
3. To examine possible effects of medications on the levels of cholesterol metabolism markers.

Basic objectives2

Others

Basic objectives -Others

Associations of biomarkers with medical conditions and diseases

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cardiovascular disease (Coronary arterial disease, cerebrovascular disease, peripheral arterial disease)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients at high-risk of cardiovascular disease (coronary arterial disease, cerebrovascular disease, peripheral arterial disease, diabetes mellitus, chronic kidney disease including those treated with dialysis, familial hypercholesterolemia), or individuals who were examined for the screening of these conditions.
2. Individuals whose cholesterol metabolism markers were already measured (serum lathosterol, campesterol, and citosterol levels)

Key exclusion criteria

1. Participants will be opt-out when the participants and/or their family members do not want to participate in this study upon information disclosure of this study.

Target sample size

3000


Research contact person

Name of lead principal investigator

1st name Tetsuo
Middle name
Last name Shoji

Organization

Osaka City University Graduate School of Medicine

Division name

Department of Vascular Medicine

Zip code

545-8585

Address

1-4-3, Asahi-machi, Abeno-ku, Osaka 545-8585, JAPAN

TEL

06-6645-3930

Email

t-shoji@med.osaka-cu.ac.jp


Public contact

Name of contact person

1st name Tetsuo
Middle name
Last name Shoji

Organization

Osaka City University Graduate School of Medicine

Division name

Osaka City University Graduate School of Medicine

Zip code

545-8585

Address

1-4-3, Asahi-machi, Abeno-ku, Osaka 545-8585, JAPAN

TEL

06-6645-3930

Homepage URL


Email

t-shoji@med.osaka-cu.ac.jp


Sponsor or person

Institute

Osaka City University

Institute

Department

Personal name



Funding Source

Organization

Bayer Yakuhin Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee of Osaka City University Graduate School of Medicine

Address

1-2-7-601, Asahi-machi, Abeno-ku, Osaka, Japan

Tel

06-6645-3456

Email

ethics@med.osaka-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪市立大学 血管病態制御学(大阪府)、大阪大学・りんくう総合医療センター(大阪府)、岩手医科大学 糖尿病・代謝内科(岩手県)、東京慈恵医科大学附属 柏病院(東京都)、九州大学病院 循環器内科(福岡県)、島根大学 総合医療講座(島根県)、神戸大学 循環器内科学(兵庫県)、広島大学 循環器内科学(広島県)、熊本大学 糖尿病・代謝・内分泌内科(熊本県)、東京女子医科大学 糖尿病センター(東京都)、宮崎大学医学部 神経呼吸内分泌代謝学分野(宮崎県)、自治医科大学 地域医療学センター(栃木県)、国立循環器病研究センター研究所 病態代謝部(大阪府)


Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 08 Month 31 Day

Date of IRB

2017 Year 10 Month 04 Day

Anticipated trial start date

2018 Year 02 Month 01 Day

Last follow-up date

2020 Year 06 Month 30 Day

Date of closure to data entry

2020 Year 06 Month 30 Day

Date trial data considered complete


Date analysis concluded

2020 Year 12 Month 31 Day


Other

Other related information

Observational study


Management information

Registered date

2017 Year 12 Month 29 Day

Last modified on

2021 Year 12 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034945


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name